Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens

Background. The optimal retreatment strategy for chronic hepatitis C virus (HCV) patients who fail directly-acting antiviral agent (DAA)-based treatment is unknown. In this study, we assessed the efficacy and safety of ledipasvir (LDV) and sofosbuvir (SOF) for 12 weeks in HCV genotype-1 (GT-1) patie...

詳細記述

保存先:
書誌詳細
出版年:Clin Infect Dis
主要な著者: Wilson, Eleanor M., Kattakuzhy, Sarah, Sidharthan, Sreetha, Sims, Zayani, Tang, Lydia, McLaughlin, Mary, Price, Angie, Nelson, Amy, Silk, Rachel, Gross, Chloe, Akoth, Elizabeth, Mo, Hongmei, Subramanian, G. Mani, Pang, Phillip S., McHutchison, John G., Osinusi, Anu, Masur, Henry, Kohli, Anita, Kottilil, Shyam
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2016
主題:
Articles and Commentaries
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706633/
https://ncbi.nlm.nih.gov/pubmed/26521268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ874
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料